US2546041011
US2546041011
Disc Medicine, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 2.38B EUR | 2.8B EUR | 2.44B EUR | 3.01B EUR |
Enterprise Value | 1.68B EUR | 2.77B EUR | 2.38B EUR | 2.95B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -8.77x | -- | -- | -- |
Price to Sales | -- | -- | -- | -- |
Price to Book | 3.69x | 4.35x | 3.55x | 4.07x |
EV/Revenue | -- | -- | -- | -- |
EV/EBITDA | -6.25x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -4.93% | -7.04% | -8.25% | -4.62% |